Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma.
Murakami M, Sun N, Greunke C, Feuchtinger A, Kircher S, Deutschbein T, Papathomas T, Bechmann N, William Wallace P, Peitzsch M, Korpershoek E, Friemel J, Gimenez-Roqueplo AP, Robledo M, J L M Timmers H, Canu L, Weber A, R de Krijger R, Fassnacht M, Knösel T, Kirchner T, Reincke M, Karl Walch A, Kroiss M, Beuschlein F.
Murakami M, et al. Among authors: kircher s.
Eur J Endocrinol. 2021 Jun 5;185(1):179-191. doi: 10.1530/EJE-20-1407.
Eur J Endocrinol. 2021.
PMID: 33983135